| 1 |
29183962 | Intestinal lymphatic HDL miR-223 and ApoA-I are reduced during insulin resistance and restored with niacin. | 2018 Mar |
1 |
| 2 |
26679079 | Effect of niacin on triglyceride-rich lipoprotein apolipoprotein B-48 kinetics in statin-treated patients with type 2 diabetes. | 2016 Apr |
4 |
| 3 |
27206947 | Effect of therapeutic interventions on oxidized phospholipids on apolipoprotein B100 and lipoprotein(a). | 2016 May-Jun |
1 |
| 4 |
27749370 | Recent explanatory trials of the mode of action of drug therapies on lipoprotein metabolism. | 2016 Dec |
5 |
| 5 |
26160958 | Effects of Extended-Release Nicotinic Acid on Apolipoprotein (a) Kinetics in Hypertriglyceridemic Patients. | 2015 Sep |
1 |
| 6 |
26515419 | Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus. | 2015 Dec |
1 |
| 7 |
23712600 | Extended-release niacin/laropiprant improves endothelial function in patients after myocardial infarction. | 2014 May |
1 |
| 8 |
24285582 | Effect of niacin on high-density lipoprotein apolipoprotein A-I kinetics in statin-treated patients with type 2 diabetes mellitus. | 2014 Feb |
1 |
| 9 |
24855368 | Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia. | 2014 |
3 |
| 10 |
22500948 | Consistency of extended-release niacin/laropiprant effects on Lp(a), ApoB, non-HDL-C, Apo A1, and ApoB/ApoA1 ratio across patient subgroups. | 2012 Jun 1 |
2 |
| 11 |
20152243 | Long-term safety and efficacy of triple combination ezetimibe/simvastatin plus extended-release niacin in patients with hyperlipidemia. | 2010 Feb 15 |
1 |
| 12 |
20371660 | Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease. | 2010 Jun |
1 |
| 13 |
19166694 | Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia. | 2009 Feb 1 |
3 |
| 14 |
19332196 | Atheroprotective lipoprotein effects of a niacin-simvastatin combination compared to low- and high-dose simvastatin monotherapy. | 2009 Apr |
1 |
| 15 |
19545870 | Management of non-high-density lipoprotein abnormalities. | 2009 Dec |
1 |
| 16 |
18420099 | Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia. | 2008 Apr 22 |
1 |
| 17 |
18566298 | Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins. | 2008 Sep |
6 |
| 18 |
18937622 | Niacin: a lipid polypill? | 2008 Nov |
1 |
| 19 |
17335774 | Critical role of cholesterol ester transfer protein in nicotinic acid-mediated HDL elevation in mice. | 2007 Apr 20 |
3 |
| 20 |
18047854 | Nicotinic acid (niacin) receptor agonists: will they be useful therapeutic agents? | 2007 Dec 3 |
1 |
| 21 |
17319473 | Evaluation of efficacy and safety of fixed dose lovastatin and niacin(ER) combination in asian Indian dyslipidemic patients: a multicentric study. | 2006 |
1 |
| 22 |
14605511 | Once-daily niacin extended release/lovastatin combination tablet has more favorable effects on lipoprotein particle size and subclass distribution than atorvastatin and simvastatin. | 2003 Fall |
1 |
| 23 |
10828094 | A quantitative assay for the non-covalent association between apolipoprotein[a] and apolipoprotein B: an alternative measure of Lp[a] assembly. | 2000 Jun |
1 |
| 24 |
11075282 | [Efficacy and safety of immediate-release niacin in patients with ischemic cardiopathy. Experience of the Instituto Nacional de CardiologĂa "Ignacio Chávez"]. | 2000 Jul-Aug |
1 |
| 25 |
10195935 | Niacin accelerates intracellular ApoB degradation by inhibiting triacylglycerol synthesis in human hepatoblastoma (HepG2) cells. | 1999 Apr |
7 |
| 26 |
9761083 | Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia. | 1998 Sep 15 |
2 |
| 27 |
8474308 | Hypolipidemic effects of nicotinic acid in patients with familial defective apolipoprotein B-100. | 1993 Feb |
1 |
| 28 |
1402634 | Metabolism of plasma low density lipoproteins in familial combined hyperlipidaemia: effect of acipimox therapy. | 1992 Oct |
1 |
| 29 |
3188982 | Effects of nicotinic acid on concentrations of serum apolipoproteins B, C-I, C-II, C-III and E in hyperlipidemic patients. | 1988 |
1 |
| 30 |
202659 | Metabolsim of apoB and apoC lipoproteins in man: kinetic studies in normal and hyperlipoproteininemic subjects. | 1978 Jan |
1 |